A1 Refereed original research article in a scientific journal

Opiate receptor blockade on human granulosa cells inhibits VEGF release




AuthorsLunger F, Vehmas AP, Furnrohr BG, Sopper S, Wildt L, Seeber B

PublisherELSEVIER SCI LTD

Publication year2016

Journal: Reproductive BioMedicine Online

Journal name in sourceREPRODUCTIVE BIOMEDICINE ONLINE

Journal acronymREPROD BIOMED ONLINE

Volume32

Issue3

First page 316

Last page322

Number of pages7

ISSN1472-6483

DOIhttps://doi.org/10.1016/j.rbmo.2015.12.006


Abstract

The objectives of this study were to determine whether the main opioid receptor (OPRM1) is present on human granulosa cells and if exogenous opiates and their antagonists can influence granulosa cell vascular endothelial growth factor (VEGF) production via OPRM1. Granulosa cells were isolated from women undergoing oocyte retrieval for IVF. Complementary to the primary cells, experiments were conducted using COV434, a well-characterized human granulosa cell line. Identification and localization of opiate receptor subtypes was carried out using Western blot and flow cytometry. The effect of opiate antagonist on granulosa cell VEGF secretion was assessed by enzyme-linked immunosorbent assay. For the first time, the presence of OPRM1 on human granulosa cells is reported. Blocking of opiate signalling using naloxone, a specific OPRM1 antagonist, significantly reduced granulosa cell-derived VEGF levels in both COV434 and granulosa-luteal cells (P < 0.01). The presence of opiate receptors and opiate signalling in granulosa cells suggest a possible role in VEGF production. Targeting this signalling pathway could prove promising as a new clinical option in the prevention and treatment of ovarian hyperstimulation syndrome. (C) 2015 The Authors. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.




Last updated on 26/11/2024 10:13:35 PM